Arnon Lavie

Tel Aviv University — Israel

Biochemistry, Genetics and Molecular Biology · Life Sciences

42h-index5.4kcitations255works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Biochemical and Molecular Research(72), Acute Lymphoblastic Leukemia research(42), Enzyme Structure and Function(34), Natural Language Processing Techniques(24), HIV/AIDS drug development and treatment(24)

Publications255 total

p53 regulates the expression of histone modifiers to restrict stemness and maintain differentiated luminal identity in breast cancer
Proceedings of the National Academy of Sciences·2025Open Access
Wind wave climate in the Eastern Mediterranean Sea over the past century from visual ship‐based observations
Limnology and Oceanography·2025Open Access
Editor’s Note: A Novel <scp>L</scp>-Asparaginase with low <scp>L</scp>-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias <i>In Vivo</i>
Cancer Research·2025Open Access
Overview of Dialog System Evaluation Track: Dimensionality, Language, Culture and Safety at DSTC 12
arXiv (Cornell University)·2025Open Access
Abstract 328: A novel human-like asparaginase - indication expansion made possible
Cancer Research·2025
A human-like glutaminase-free asparaginase is highly efficacious in ASNSlow leukemia and solid cancer mouse xenograft models
Cancer Letters·2024· 6 citedOpen Access
Safety and Efficacy of a Novel Mammalian-Derived Asparaginase without Glutaminase Activity in Combination with Venetoclax for Acute Myeloid Leukemia
Blood·2024Open Access
ECoh: Turn-level Coherence Evaluation for Multilingual Dialogues
arXiv (Cornell University)·2024Open Access
A Human-Like Glutaminase-Free Asparaginase is Highly Efficacious in Asnslow Leukemia and Solid Cancer Mouse Xenograft Models
SSRN Electronic Journal·2024· 2 citedOpen Access
ECoh: Turn-level Coherence Evaluation for Multilingual Dialogues
2024· 1 citedOpen Access
P320: A NOVEL MAMMALIAN L-ASPARAGINASE WITH NO L-GLUTAMINASE ACTIVITY IS HIGHLY EFFICACIOUS AGAINST T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN VIVO
HemaSphere·2023Open Access
Supplementary Data from A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias &lt;i&gt;In Vivo&lt;/i&gt;
2023Open Access
Supplementary Data from A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias &lt;i&gt;In Vivo&lt;/i&gt;
2023Open Access
Data from A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias &lt;i&gt;In Vivo&lt;/i&gt;
2023Open Access
Data from A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias &lt;i&gt;In Vivo&lt;/i&gt;
2023Open Access
&lt;i&gt;In vivo&lt;/i&gt; stabilization of a less toxic asparaginase variant leads to a durable antitumor response in acute leukemia
Haematologica·2022· 16 citedOpen Access
Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy
Cancers·2022· 124 citedOpen Access
pH-Dependent Mechanisms of Influenza Infection Mediated by Hemagglutinin
Frontiers in Molecular Biosciences·2021· 38 citedOpen Access
The spleen as a sanctuary site for residual leukemic cells following ABT-199 monotherapy in ETP-ALL
Blood Advances·2021· 20 citedOpen Access
MT-Telescope: An interactive platform for contrastive evaluation of MT systems
2021· 2 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Manfred Konrad(17), Ilme Schlichting(7), Jochen Reinstein(7), Roger S. Goody(7), Ying Su(6), Alan S. Fanning(5), James M. Anderson(5), Karen N. Allen(5), Dagmar Ringe(5), Nils Ostermann(5), R. Brundiers(5), Nikolina Sekulić(5), J. Nomme(5), E. Sabini(4), Stephan Ort(4), Hien Anh Thi Nguyen(4), Amanda M. Schalk(4), T. Veit(4), Saugata Hazra(4), Michael Caffrey(3)